Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

December 1, 2024

Conditions
Positron Emission TomographyPancreatic NeoplasmsIgestive System Neoplasms
Interventions
RADIATION

[18F]F-H3RESCA-3A12及[68Ga]Ga-NOTA-3A12

The dose of \[18F\]RCCB6 was calculated based on the patient's body weight to be 3.7 MBq \[0.1 MCi\]/kg, and the method of administration was intravenous push, with a single visualization administered once.

Trial Locations (1)

200235

RECRUITING

PET Center, Huashan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

YiHui Guan

OTHER